Specific Cell Protein Mismatches May Improve Stem Cell Transplant Results

Children's Oncology Group (COG)


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL

Trial Name

Killer Immunoglobulin-Like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Stem Cell Transplantation (SCT) for AML With Monosomy 7,-5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute Myelogenous Leukemia (AML) in Children

What is the trial about?

To see whether specific cell protein mismatches (KIR receptor-ligand) may improve stem cell transplant results.

Who can participate?

> 1 month and < 30 years of age.

What is involved?

Length of study is 6 months. Standard cancer care plus KIR testing.

Contact Nemours Clinical Trials

Trial Name: Killer Immunoglobulin-Like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Stem Cell Transplantation (SCT) for AML With Monosomy 7,-5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute Myelogenous Leukemia (AML) in Children

COG#: AAML05P1

Contact Information

(800) 354-5690
clinicaltrials@nemours.org